PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers advance fight against biggest hidden virus

Cardiff University and La Jolla Institute collaboration makes headway in developing a vaccine for the leading infectious cause of congenital birth defects

2013-03-14
(Press-News.org) A virus that most people have probably never heard of, yet most of us carry, is the number 1 infectious cause of congenital birth defects. One in 750 children are born with, or develop, permanent disabilities such as hearing loss or brain damage as a result of CMV (cytomegalovirus) infection in the womb. Major research efforts are underway to combat this invidious disease.

Researchers from Cardiff University and the La Jolla Institute, California, have discovered a previously unknown cellular mechanism that could prove critical in creating a CMV vaccine.

"CMV is recognised as a major pathogen by Clinicians, yet there is little public awareness of the virus." says Professor Gavin Wilkinson from the Cardiff University School of Medicine. "More children have disabilities from this disease than other well-known congenital problems, such as Down's syndrome or fetal alcohol syndrome."

"We have identified a novel trick that this virus uses to hide from immune detection," says La Jolla Institute scientist Chris Benedict, Ph.D., a CMV expert. "By uncovering this mechanism, we've provided an important piece of the CMV puzzle that could enable vaccine counter strategies that flush out and eliminate virus-infected cells." The finding was published online today in the journal Cell, Host & Microbe.

CMV's stealthy nature keeps it under wraps. In common with other member of the herpes family of viruses that cause cold sores, chicken pox and other maladies - once contracted, CMV never goes away. Most people are unaware they have contracted the virus, nor generally do they exhibit any visible symptoms during lifelong carriage. However, research is now revealing how hard that the immune system has to fight to keep CMV at bay.

"In addition to causing terrible birth defects and severe disease in patients with autoimmune disease, CMV induces changes in the immune response of anyone carrying the virus," according to Professor Wilkinson. The constant struggle to control CMV contributes to the immune system 'tiring' over time.

In their study, researchers found that a specific CMV gene (called UL141) blocks the ability of two key immune pathways to kill CMV-infected cells. As their names imply, these two pathways – known as TRAIL "death receptor" 1 and 2 – normally act to kill infected cells.

TRAIL death receptors have already been actively targeted in anti-tumor therapies. While important in cancer, it has also become quite clear that TRAIL signaling by the immune system is very significant in viral infections, such as CMV. By illuminating the UL141 gene as inhibiting TRAIL's ability to carry out its killing function, the researchers believe they have identified a pivotal cellular defence that needs to be considered when developing an effective vaccine.

The TRAIL molecule and its receptors were discovered about 15 years ago and are members of the tumor necrosis factor family of molecules, which have proven extremely important in medical research efforts to control or prevent many diseases. The research team was the first to identify a herpes virus function (UL141) interacting with the TRAIL Death receptors, and it is only the second known protein known to do so (TRAIL is the other).

Ed Mocarski, Ph.D., a scientist at the Emory University School of Medicine's Vaccine Center, praised the discovery for identifying some of the key cells involved in the ongoing tug-of-war between CMV and the immune system. "This finding puts on the table the importance of TRAIL signaling in host (our body's) defense and how the virus works to block these efforts," says Dr. Mocarski, whose research focuses on new ways to combat CMV. "This knowledge could set the stage for developing ways to boost the adaptive immune response which could ultimately aid in developing an effective vaccine."

### Useful links:

Cardiff School of Medicine La Jolla Institution for Allergy and Immunology

Notes to Editors: For further information or to arrange an interview, please contact: Tomas Llewelyn Barrett
Public Relations
Cardiff University
Mobile: 07-950-792-532 Or:

Bonnie Ward
contact@liai.org
(US) 619-303-3160

Cardiff University Cardiff University is recognised in independent government assessments as one of Britain's leading teaching and research universities and is a member of the Russell Group of the UK's most research intensive universities. Among its academic staff are two Nobel Laureates, including the winner of the 2007 Nobel Prize for Medicine, University Chancellor Professor Sir Martin Evans. Founded by Royal Charter in 1883, today the University combines impressive modern facilities and a dynamic approach to teaching and research. The University's breadth of expertise in research and research-led teaching encompasses: the humanities; the natural, physical, health, life and social sciences; engineering and technology; preparation for a wide range of professions; and a longstanding commitment to lifelong learning. Three major new Research Institutes, offering radical new approaches to neurosciences and mental health, cancer stem cells and sustainable places were announced by the University in 2010. http://www.cardiff.ac.uk

About La Jolla Institute Founded in 1988, the La Jolla Institute for Allergy & Immunology is a biomedical research nonprofit focused on improving human health through increased understanding of the immune system. Its scientists carry out research seeking new knowledge leading to the prevention of disease through vaccines and the treatment and cure of infectious diseases, cancer, inflammatory and autoimmune diseases such as rheumatoid arthritis, type 1 (juvenile) diabetes, Crohn's disease and asthma. La Jolla Institute's research staff includes more than 150 Ph.D.s and M.D.s. To learn more about the Institute's work, visit http://www.liai.org. END



ELSE PRESS RELEASES FROM THIS DATE:

Mutations in VCP gene implicated in a number of neurodegenerative diseases

2013-03-14
New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of neurological conditions including a form of dementia called Inclusion Body Myopathy, Paget's Disease of the Bone and Frontotemporal Dementia (IBMPFD), and the motor neuron disease Amyotrophic Lateral Sclerosis (ALS). Single mutations in one gene rarely cause such different diseases. This study shows that these mutations disrupt energy production in cells shedding new light on the role of VCP in these multiple disorders. In healthy cells VCP helps remove damaged ...

New cancer diagnostic technique debuts

2013-03-14
Valdivia, Chile, and Washington, D.C.—Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies. Now a team of Chilean researchers at The Centro de Estudios Científicos (CECs), with the collaboration of Carnegie's Wolf Frommer, has devised a molecular sensor that can detect levels of lactate in individual cells in real time. Prior to this advance, no other measurement ...

Problems of pathological gambling differ for younger and older gamblers

2013-03-14
To successfully treat pathological gambling, you need to intervene at an early stage, according to Susana Jiménez-Murcia from the University Hospital of Bellvitge in Spain and colleagues. Their study shows that a patient's age influences how severe the psychopathology and clinical aspects of pathological gambling are. Their work is published online in Springer's Journal of Gambling Studies. These days, access to 24-hour, uncontrolled gambling is straightforward thanks largely to the internet. People can access both classic and modern games, from slot machines and lotteries ...

Pig brain models provide insights into human cognitive development

2013-03-14
URBANA – A mutual curiosity about patterns of growth and development in pig brains has brought two University of Illinois research groups together. Animal scientists Rod Johnson and Ryan Dilger have developed a model of the pig brain that they plan to use to answer important questions about human brain development. "It is important to characterize the normal brain growth trajectory from the neonatal period to sexual maturity," said Johnson. "Until we know how the brain grows, we don't know what is going to change," added Dilger. In cooperation with the Beckman Institute, ...

Teen sexting, the gender gap

2013-03-14
Sexting: Involves sending sexually explicit messages and/or photographs, primarily between mobile phones using the SMS system was first reported in 2005. It is an obvious portmanteau of "sex" and "texting"; the word was added to the Merriam-Webster's Collegiate Dictionary in August 2012. 4% of mobile phone-owning teens claim to have sent sexually suggestive, nude or nearly nude images or videos of themselves to someone else via a mobile device while 15% claim to have received such material from someone they know. With contract cell phones and cheaper multimedia messaging ...

Olive oil makes you feel full

2013-03-14
Work groups at Technische Universität München (TUM) under Prof. Peter Schieberle and at the University of Vienna under Prof. Veronika Somoza studied four different edible fats and oils: Lard, butterfat, rapeseed oil and olive oil. Over a period of three months, the study participants ate 500 grams of low-fat yoghurt enriched with one of the four fats or oils every day – as a supplement to their normal diet. "Olive oil had the biggest satiety effect," reports Prof. Peter Schieberle, Head of the TUM Chair of Food Chemistry and Director of the German Research Center for ...

New details of atomic structure of water under extreme conditions found

2013-03-14
Scientist from Dortmund, Helsinki, Potsdam, and the ESRF have revealed details of the microscopic atomic structure of water under extreme conditions. The results have now been published in the Proceedings of the National Academy of Sciences of the USA. Liquid water remains a mystery even after decades of dedicated scientific investigations and researchers still struggle to fully describe its unusual structure and dynamics. At high temperatures and high pressures, water is in the so called supercritical state and exhibits a number of peculiar characteristics that are ...

Surprising rate of women depressed after baby

2013-03-14
CHICAGO --- A surprisingly high number of women have postpartum depressive symptoms, according to a new, large-scale study by a Northwestern Medicine® researcher. This is the largest scale depression screening of postpartum women and the first time a full psychiatric assessment has been done in a study of postpartum women who screened positive for depression. The study, which included a depression screening of 10,000 women who had recently delivered infants at single obstetrical hospital, revealed a large percentage of women who suffered recurrent episodes of major ...

Novel treatment approach for bladder pain using a herpes simplex virus vector reported

Novel treatment approach for bladder pain using a herpes simplex virus vector reported
2013-03-14
New Rochelle, NY, March 14, 2013—Severe chronic pain associated with conditions such as bladder pain syndrome/interstitial cystitis often require the use of opioid medication, with the risk of dependency and serious adverse reactions. An alternative treatment strategy increases the levels of a naturally occurring painkiller in and around the nerves that deliver pain signals to the bladder. This new therapeutic approach is described in an article in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Human ...

Researchers building stronger, greener concrete with biofuel byproducts

2013-03-14
MANHATTAN, KAN. -- Kansas State University civil engineers are developing the right mix to reduce concrete's carbon footprint and make it stronger. Their innovative ingredient: biofuel byproducts. "The idea is to use bioethanol production byproducts to produce a material to use in concrete as a partial replacement of cement," said Feraidon Ataie, doctoral student in civil engineering, Kabul, Afghanistan. "By using these materials we can reduce the carbon footprint of concrete materials." Concrete is made from three major components: portland cement, water and aggregate. ...

LAST 30 PRESS RELEASES:

Grant to support new research to address alcohol-related partner violence among sexual minorities

Biodiversity change amidst disappearing human traditions

New approaches to synthesize compounds for pharmaceutical research

Cohesion through resilient democratic communities

UC Santa Cruz chemists discover new process to make biodiesel production easier, less energy intensive

MD Anderson launches Institute for Cell Therapy Discovery & Innovation to deliver transformational new therapies

New quantum encoding methods slash circuit complexity in machine learning

New research promises an unprecedented look at how psychosocial stress affects military service members’ heart health

Faster measurement of response to antibiotic treatment in sepsis patients using Dimeric HNL

Cleveland Clinic announces updated findings in preventive breast cancer vaccine study

Intergenerational effects of adversity on mind-body health: Pathways through the gut-brain axis

Watch this elephant turn a hose into a sophisticated showering tool

Chimpanzees perform better on challenging computer tasks when they have an audience

New medical AI tool identifies more cases of long COVID from patient health records

Heat waves and adverse health events among dually eligible individuals 65 years and older

Catastrophic health expenditures for in-state and out-of-state abortion care

State divorce laws, reproductive care policies, and pregnancy-associated homicide rates

Emerging roles of high-mobility group box-1 in liver disease

Exploring the systematic anticancer mechanism in selected medicinal plants

University of Cincinnati researchers pen editorial analyzing present, future of emergency consent in stroke trials

Scarlet Macaw parents ‘play favorites,’ purposefully neglect younger chicks

One gene provides diagnoses for 30 patients whose condition was unexplained for years

Current practice and emerging endoscopic technology in the diagnosis of colorectal cancer

Decoding 17-beta-hydroxysteroid dehydrogenase 13: A multifaceted perspective on its role in hepatic steatosis and associated disorders

Key pathway leading to neurodegeneration in early stages of ALS identified

Ferroptosis in regulating treatment tolerance of digestive system tumors

A promising future in pancreatic incidentaloma detection

Stabilizing lithium-ion batteries: The vanadium touch

Innovative approaches to the surgical challenges in the management of gastroschisis

Mouse models for the study of liver fibrosis regression in vivo and ex vivo

[Press-News.org] Researchers advance fight against biggest hidden virus
Cardiff University and La Jolla Institute collaboration makes headway in developing a vaccine for the leading infectious cause of congenital birth defects